e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Immune responses for the diagnosis of tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Patients with culture positive active tuberculosis but negative "QuantiFERON-TB Gold in Tube Test" (QFT) – A critical view on the cut-off in clinical praxis
S. Vesenbeckh, T. Bergmann, H. Mauch, H. Rüssmann, N. Schönfeld, T. Blum, T. Bauer (Berlin, Germany)
Source:
Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis
Session:
Immune responses for the diagnosis of tuberculosis
Session type:
E-Communication Session
Number:
282
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Vesenbeckh, T. Bergmann, H. Mauch, H. Rüssmann, N. Schönfeld, T. Blum, T. Bauer (Berlin, Germany). Patients with culture positive active tuberculosis but negative "QuantiFERON-TB Gold in Tube Test" (QFT) – A critical view on the cut-off in clinical praxis. Eur Respir J 2010; 36: Suppl. 54, 282
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Prospective study of concordance between tuberculin skin test (TST) and interferon-γ (IFNγ) assay in asymptomatic paediatric tuberculosis (TB) contacts
Source: Annual Congress 2009 - Diagnostic tools in paediatric respiratory infection
Year: 2009
The value of tuberculin skin test (TST) and interferon – gamma release assay (IGRA) in the diagnosis of latent tuberculosis infection (LTBI) according to age group
Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis
Year: 2010
Negative predictive value of serum-procalcitonin (PCT) for active pulmonary tuberculosis (pTB)
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009
Cut-off point for tuberculin skin test (TST) and QuantiFERON (QTF) in the diagnosis of tuberculosis infection (TI) in a study of contacts of tuberculosis (TB)
Source: Annual Congress 2012 - Tuberculosis and immunologic assays
Year: 2012
Validation of the MGIT 960 technique for 2
nd
line drug susceptibility testing (DST) of
Mycobacterium tuberculosis
Source: Annual Congress 2010 - Emerging drug resistance in tuberculosis
Year: 2010
Comparison of tuberculin skin test (TST) and QuantiFERON-TB-Gold in Tube (QFT) in the diagnosis of latent tuberculosis infection (LTBI) in a prospective community study of contacts of tuberculosis (TB)
Source: Annual Congress 2010 - What is new in the diagnosis of tuberculosis?
Year: 2010
QuantiFERON TB gold – a new component of follow up in TB contacts from vulnerable groups
Source: Annual Congress 2009 - Tuberculosis contact screening
Year: 2009
Clinical pattern of extrapulmonary tuberculosis (EPT) as observed at a teaching hospital in India – are we missing them?
Source: Annual Congress 2009 - Pulmonary infections
Year: 2009
The significance of the antigen-specific IFN-γ release assay
in vitro
for differential diagnosis between sarcoidosis and tuberculosis (TB) patients
Source: Annual Congress 2010 - What is new in the diagnosis of tuberculosis?
Year: 2010
The influence of a high negative control on the interpretation of QuantiFERON Gold in Tube (QFN) results
Source: Annual Congress 2011 - Risk assessment for tuberculosis
Year: 2011
Evidence assessment on the use of IGRA testing in diagnosing latent tuberculosis – A TBNET review
Source: Annual Congress 2010 - Interferon-gamma releases assays (IGRAs) for the diagnosis of tuberculosis: what is the role?
Year: 2010
Outcomes of early interferon-gamma release assay (IGRA) testing in recent contacts of smear positive pulmonary tuberculosis (TB)
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013
QuantiFERON-TB GIT (QFT-GIT)
vs
TST in diagnosis of latent tuberculosis (TB) infection (LTBI) in household TB contacts in poland
Source: Annual Congress 2009 - Tuberculosis contact screening
Year: 2009
Comparison of the accuracy of QuantiFERON TB gold in tube vs QuantiFERON-TB plus
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016
The specificity of a new skin test – Diaskintest (recombinant protein CFP10-ESAT6) in patients with sarcoidosis and non-tuberculous pulmonary diseases
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011
Diagnostic accuracy of the novel C-Tb skin test for LTBI, results from two phase III trials
Source: International Congress 2016 – Latent tuberculosis infection
Year: 2016
Quantiferon-TB Gold in tube assay for detecting latent TB infection in immigrants and TB contacts
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013
The value of immunological methods in the diagnosis of tuberculosis in patients with HIV
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
Interferon-γ release assays (IGRA) vs. tuberculin skin testing (TST) for detecting latent tuberculosis infection (LTBI) in chronic hemodialysis (CH) patients
Source: Annual Congress 2008 - New tools in tuberculosis diagnosis
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept